Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Altimmune, Inc. (ALT): A Bull Case Theory

We came across a bullish thesis on Altimmune, Inc. (ALT) on WallStreetBets subreddit page by Old-Pomegranate3634. In this article, we will summarize the bulls’ thesis on ALT. ALT Technologies, Inc. share was trading at $6.10 as of Oct 7th. ALT’s trailing P/E was 1.82 according to Yahoo Finance.

[caption id="attachment_366816" align="aligncenter" width="750"] design36/Shutterstock.com[/caption]

Altimmune (ALT) is developing a promising drug pemvidutide for the growing obesity market. This GLP-1/glucagon dual receptor agonist will address obesity and metabolic...